AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.01.22	AstraZeneca Signs Deal With Neurimmune For Transthyretin Amyloid Cardiomyopathy Drug (RTTNews)
27.12.21	Biotech Stocks Facing FDA Decision In January 2022 (RTTNews)
23.12.21	AstraZeneca's Evusheld Retains Neutralizing Activity Against Omicron Variant In Studies (RTTNews)
23.12.21	AstraZeneca: University Of Oxford Study Supports Use Of Vaxzevria As Booster Against Omicron (RTTNews)
22.12.21	EnPro Industries Closes Sale Of Compressor Products International To Howden (RTTNews)
21.12.21	AstraZeneca: Ultomiris Accepted For FDA Priority Review For GMG - Quick Facts (RTTNews)
20.12.21	AstraZeneca And Amgen's Tezspire Approved In US For Severe Asthma (RTTNews)
16.12.21	AstraZeneca's Evusheld Retains Neutralizing Activity Against Omicron Variant (RTTNews)
15.12.21	AstraZeneca Exercises License Option For Oncolytic Virus Generated From Invir.IO Collaboration (RTTNews)
14.12.21	Samsung Biologics, AstraZeneca Expand Partnership To Include COVID-19 And Cancer Therapy (RTTNews)
14.12.21	Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy (PR Newswire)
13.12.21	AstraZeneca Elated On Calquence Data, IMGN's IMGN632 Appears To Be Promising In AML, XRTX On Watch (RTTNews)
13.12.21	AZN : Calquence Reduces Risk Of Disease Progression/death By 71% In Phase III Trial On Blood Cancer (RTTNews)
09.12.21	AZN's Antibody Authorized For COVID-19, RDUS Shrinks, ZYME On Watch, FDA Panel Snubs RETA (RTTNews)
09.12.21	FDA Authorizes AstraZeneca's Antibody Combination For Preventive Use Against COVID-19 (RTTNews)
07.12.21	AstraZeneca, Ionis In Deal To Develop And Commercialise Eplontersen - Quick Facts (RTTNews)
30.11.21	AstraZeneca's Lynparza Granted Priority Review In U.S. For High-risk Early Breast Cancer (RTTNews)
29.11.21	Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed (RTTNews)
24.11.21	HUTCHMED, AstraZeneca Initiate Phase III Trial Of ORPATHYS& TAGRISSO In Certain Lung Cancer Patients (RTTNews)
18.11.21	AstraZeneca Reports Positive Data From Two AZD7442 COVID-19 Phase III Trials (RTTNews)
16.11.21	AstraZeneca Supplies 2 Bln Doses Of COVID-19 Vaccine In Last 11 Months After First Approval (RTTNews)
13.11.21	Moderna : Interim Data From Phase 1 Study Of MRNA Triplet Shows Evidence Of Anti-tumor Activity (RTTNews)
12.11.21	AstraZeneca Stock Down On Q3 Loss; Maintains FY21 View (RTTNews)
12.11.21	AstraZeneca Slips To Loss In Q3, Revenues Climb; Backs FY21 Outlook - Quick Facts (RTTNews)
03.11.21	Integral Molecular Reaches Antibody License Deal With AstraZeneca For Oncology Therapeutics (RTTNews)
01.11.21	AstraZeneca Agrees To Transfer Global Rights To Eklira, Duaklir To Covis Pharma (RTTNews)
01.11.21	Hutchmed, AstraZeneca Initiate Late Stage Trial Of Savolitinib-Imfinzi On Kidney Cancer (RTTNews)
25.10.21	AstraZeneca: Imfinzi Plus Chemotherapy Significantly Improves Survival In 1st-line Advanced BTC (RTTNews)
18.10.21	AstraZeneca Recommends Shareholders Reject TRC Capital's Mini-Tender Offer - Quick Facts (RTTNews)
15.10.21	AZN : Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer (RTTNews)
11.10.21	AstraZeneca : Phase III Trial Shows AZD7442 Reduces Risk Of Developing Severe COVID-19 Or Death (RTTNews)
08.10.21	AstraZeneca: FDA Grants Orphan Drug Designation To Tezepelumab For Eosinophilic Esophagitis (RTTNews)
05.10.21	AstraZeneca Seeks Emergency Nod In US For AZD7442 To Prevent Symptomatic COVID-19 (RTTNews)
04.10.21	AstraZeneca's Enhertu Receives Fourth U.S. Breakthrough Therapy Designation (RTTNews)
24.09.21	AstraZeneca: Lynparza PROpel Phase III Trial In 1st-line MCRPC Meets Primary Endpoint (RTTNews)
23.09.21	RedHill Biopharma Announces Movantik Patent Litigation Settlement With Aurobindo (RTTNews)
20.09.21	AstraZeneca: Enhertu Triples Progression-free Survival In Phase III DESTINY-Breast03 Trial (RTTNews)
18.09.21	AZN : Imfinzi Plus Chemotherapy Triples Patient Survival At 3-yrs In ES-Small Cell Lung Cancer (RTTNews)
18.09.21	AstraZeneca : Enhertu Shows Robust And Durable Tumor Response Of 54.9% In Patients With Lung Cancer (RTTNews)
17.09.21	AZN : Imfinzi Plus Novel Immunotherapies Improve Clinical Outcomes For Patients With Lung Cancer (RTTNews)
09.09.21	AstraZeneca Reports Positive Results From Late-stage Trial For Lung Cancer Treatment (RTTNews)
09.09.21	AstraZeneca: MANDALA, DENALI Phase III Trials Of PT027 For Asthma Meet All Primary Goals (RTTNews)
08.09.21	Hutchmed Says First Patient Dosed In China Phase III Trial Of Orpathys And Tagrisso In Lung Cancer (RTTNews)
05.09.21	Amgen's Tezepelumab Reduces Exacerbations In Patients With Severe Asthma & Comorbid Nasal Polyps (RTTNews)
03.09.21	EU, AstraZeneca Agree On Delivery Of Remaining 200 Mln COVID-19 Vaccine Doses (RTTNews)
03.09.21	AstraZeneca: European Commission Approves Expanded Use Of Ultomiris For Children, Adolescents (RTTNews)
31.08.21	AstraZeneca's FLUMIST QUADRIVALENT Available For Flu Vaccination - Quick Facts (RTTNews)
26.08.21	AstraZeneca's Forxiga Approved In Japan For Chronic Kidney Disease - Quick Facts (RTTNews)
26.08.21	AstraZeneca : Phase III Trial In Wilson Disease Meets Primary Endpoint (RTTNews)
20.08.21	AstraZeneca: Alexion To Discontinue CHAMPION-ALS Phase 3 Trial Of Ultomiris In ALS (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	247.70	0.41 %	K V
Sonova Hldg	291.90	-0.31 %	K V
Givaudan	3’882.00	-0.64 %	K V
Swisscom	498.20	-0.66 %	K V
Kuehne+Nagel Int	200.90	-0.69 %	K V
Lonza Grp	518.40	-1.86 %	K V
Holcim	85.28	-1.95 %	K V
Part Grp Hldg	1’191.50	-2.10 %	K V
UBS Group	26.28	-2.27 %	K V
Sika	213.60	-2.29 %	K V

mehr

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer